Combination of CD47 and CD68 expression predicts survival in eastern-Asian patients with non-small cell lung cancer.

MLA

Fu, Fangqiu, et al. “Combination of CD47 and CD68 Expression Predicts Survival in Eastern-Asian Patients with Non-Small Cell Lung Cancer.” Journal of Cancer Research and Clinical Oncology, vol. 147, no. 3, Mar. 2021, pp. 739–47. EBSCOhost, https://doi.org/10.1007/s00432-020-03477-3.

APA

Fu, F., Zhang, Y., Gao, Z., Zhao, Y., Wen, Z., Han, H., Li, Y., Hu, H., & Chen, H. (2021). Combination of CD47 and CD68 expression predicts survival in eastern-Asian patients with non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology, 147(3), 739–747. https://doi.org/10.1007/s00432-020-03477-3

Chicago

Fu, Fangqiu, Yang Zhang, Zhendong Gao, Yue Zhao, Zhexu Wen, Han Han, Yuan Li, Hong Hu, and Haiquan Chen. 2021. “Combination of CD47 and CD68 Expression Predicts Survival in Eastern-Asian Patients with Non-Small Cell Lung Cancer.” Journal of Cancer Research and Clinical Oncology 147 (3): 739–47. doi:10.1007/s00432-020-03477-3.